Skip to content
Trial Agents

Cyberchrome

Cyberchrome is recorded as a service provider in 6 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.

6distinct trials
6recorded service labels
0trials with learnings

Data snapshot: 2026-10-09 · About the data

Clinical trial experience

Showing 6 of 6 trials · Latest update first

A Randomized, Blinded, Placebo-Controlled, Phase 1 Single Ascending Dose Study in Healthy Adult Male Volunteers and an Open-Label Multiple Ascending Dose Study with Long-Term Extension in Pediatric SMA Participants Previously Treated with Onasemnogene Abeparvovec (Zolgensma™) to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB115.

Sponsor Biogen Idec Research Limited

Start (EU)
Latest update
Estimated end

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer’s Disease or Mild Alzheimer’s Disease Dementia

Sponsor Biogen Idec Research Limited

Start (EU)
Latest update
Estimated end

A Phase 3, Randomized, Double-Blinded Study to Evaluate the Safety and Efficacy of Salanersen (BIIB115) After Onasemnogene Abeparvovec Treatment in Infants with Genetically Diagnosed Spinal Muscular Atrophy

Sponsor Biogen Idec Research Limited

Start (EU)
Not reported
Latest update
Estimated end

Questions about this trial experience

What services are recorded for Cyberchrome?

The 2026-10-09 snapshot links Cyberchrome to 6 distinct CTIS trials. Recorded services include Materials for Patient recruitment services, Patient Rec/Ret Documents, Patient recruitment material, Printing and shipping services, among 6 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.

Which therapeutic areas and study phases are recorded for Cyberchrome?

The most frequently recorded therapeutic areas are Neurology, Dermatology, Genetic and Congenital Disorders, Immunology. Recorded phases include Phase 3, Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.

In which countries are trials linked to Cyberchrome conducted?

The linked trials record locations in 18 countries, including Poland, Germany, France, Belgium, Spain. These are trial locations, not confirmed office locations or countries where Cyberchrome delivered services.

What can this page tell me about Cyberchrome's trial experience?

Browse 6 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.

About this data & company names

One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.

Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.

Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Cyberchrome. Legacy brands remain separate unless explicitly matched in the name registry.

View recorded company names
  • Cyberchrome Inc.

Never miss a new clinical trial insight

We continuously analyze new and updated clinical trial data and publish practical, evidence-led reports for clinical leaders.